Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NACDS staff reductions

Executive Summary

The National Association of Chain Drug Stores will reduce its full-time staff by 5% over the next several weeks, the association said Aug. 8. The reduction will bring the association's Alexandria, Va. headquarters staff down to about 113 employees from 120. NACDS indicated that its conference revenues have been down in the past year...

You may also be interested in...



NACDS Stakes Claim On The Hill: Real Estate Lobbyist To Head Govt. Affairs

The National Association of Chain Drug Stores' government affairs staff will seek to expand its lobbying territory under the direction of former real estate lobbyist Lee Verstandig

US High Court Punts On ‘Objective Falsity’ FCA Standard

Can a false-claims suit be filed if doctors have different opinions about whether a treatment was necessary? The Supreme Court won’t say.

Warning Letter Close-Outs – February 2021

No device-related close-out letters were released by the US FDA last month.

UsernamePublicRestriction

Register

ID1135947

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel